Divine Aleru

Divine Aleru, Microbiome Signatures Research Coordinator

About

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

Recent Posts

2025-09-02

The many “faces” of copper in medicine and treatment

This review explores copper’s essential roles in human health and its involvement in diseases like Wilson’s disease, Alzheimer’s, and cancer. It highlights copper’s dual role in disease progression and therapeutic strategies for copper imbalances.

2025-09-02

Copper: Toxicological relevance and mechanisms.

This study highlights how Cu imbalance leads to oxidative stress and cellular toxicity, contributing to liver and neurological diseases. It emphasizes the need for tight Cu regulation and offers insights into potential biomarkers and therapeutic strategies for Cu-related disorders.

2025-09-02

Histatins: Salivary peptides with copper(II)- and zinc(II)-binding motifs

This study examines the copper-binding properties of Hist-5, a salivary peptide, and its role in combating Candida albicans infections. The findings highlight the critical role of copper ions in enhancing the peptide’s antimicrobial activity through specific metal-binding motifs.

2025-09-02

Copper at the Front Line of the Host-Pathogen Battle

This review explores the critical role of copper in microbial pathogenesis, focusing on how the host uses it as an antimicrobial weapon and how pathogens resist Cu toxicity. It suggests potential therapeutic avenues targeting Cu resistance mechanisms.

2025-09-02

Copper in microbial pathogenesis: Meddling with the metal

This review explores copper’s role in microbial pathogenesis, highlighting its use by hosts as an antimicrobial weapon and the resistance mechanisms developed by pathogens. It discusses copper’s involvement in immune defense and fungal virulence, offering insights into potential therapeutic strategies.

2025-08-29

Chelation in Metal Intoxication

This review discusses advancements in chelation therapy for treating metal toxicity, focusing on chelating agents, combination therapies, and antioxidants. Key findings highlight the effectiveness of MiADMSA and the potential for improved treatments.

2025-08-28

Lead(II) Binding in Natural and Artificial Proteins

This review defines how lead binding in proteins drives host enzyme inhibition and signaling errors while microbial operons export and precipitate Pb(II), reshaping niche metal availability and competitive fitness.

2025-08-28

Deferoxamine B: A Natural, Excellent and Versatile Metal Chelator

A comprehensive review of Deferoxamine B metal chelator links siderophore chemistry, microbial uptake, and clinical chelation/imaging, highlighting speciation across metals—including Pb(II)—and implications for microbiome-related metal competition.

2025-08-28

Factors affecting the absorption and excretion of lead in the rat

An in vivo radiotracer study defines lead absorption and excretion in the rat: duodenal, bile-modulated uptake; competition with Fe/Zn/Ca; iron deficiency–enhanced absorption; erythrocyte transport; early renal–hepatic handling; biliary plus urinary clearance; and bone storage.